Phosphatidylserine-containing platelet phospholipid membranes (PS-exposed platelet membrane)

Phosphatidylserine (PS)-containing platelet phospholipid membranes serve as a critical catalytic platform for the blood coagulation cascade (Zwaal & Schroit, 1997). In resting platelets, PS is actively sequestered in the inner leaflet of the plasma membrane by flippases, but upon activation by stimuli such as thrombin or collagen, a calcium-dependent scramblase facilitates the translocation of PS to the outer leaflet (Heemskerk et al., 2002). This exposure of negatively charged PS provides a high-affinity binding site for the gamma-carboxyglutamic acid (Gla) domains of Vitamin K-dependent clotting factors, including Factors II, VII, IX, and X, in the presence of calcium ions (StatPearls, 2023). This assembly, central to the cell-based model of coagulation, dramatically accelerates the formation of the tenase and prothrombinase complexes, leading to a burst of thrombin generation and subsequent fibrin clot formation (Lentz, 2003). Dysregulation of PS exposure is linked to various pathologies; for instance, excessive exposure promotes arterial and venous thrombosis, while a deficiency in PS exposure, as seen in Scott Syndrome, results in severe bleeding diathesis (Zwaal & Schroit, 1997). Consequently, this membrane surface is a target for diagnostic imaging agents like Annexin V and is being explored for therapeutic interventions, such as Bavituximab, to modulate coagulation and inflammation in disease states (ClinicalTrials.gov).

Other names

Procoagulant platelet surfaceActivated platelet membranePhosphatidylserine-rich membranePS-exposed surfacePlatelet procoagulant membrane

Provides a negatively charged catalytic scaffold that facilitates the assembly and activation of Vitamin K-dependent coagulation factor complexes (tenase and prothrombinase).